About GENIE Therapeutics
GENIE Therapeutics is a private company based in Wilmington, Delaware, incorporated in 2019 in Delaware. It has reported $0 raised in one offering on Form D since July 2023. Its chief executive is Aaron Tabor.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jul 27, 2023amended Nov 17, 2023 | $0target not set | 0 | — | EquityRule 506(c) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GENIE Therapeutics's Form D filed Nov 17, 2023.
AT
Aaron Tabor
Chief Executive Officer